PASG
Passage Bio, Inc. · Healthcare
Orbimed Advisors LLC bought $6.7M of Passage Bio, Inc.
10% owner
Bought$6,719,400
$18.00Price
373,300Shares
+7%Stake
What PASG did for a copier
Prices for PASG after this filing aren't in yet.
Orbimed Advisors LLC's record
35 other buys with 3 months of prices since 2016: on average −12.5% against the S&P 500, and 12 of 35 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Feb 28. Filed Tue, Mar 3, 7:07 PM ET, after the close. Not investment advice.